Company profile PMVP

PMV Pharmaceuticals Inc
pmv pharmaceuticals, inc., a precision oncology company, discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. its lead product candidate is pc14586, a small molecule that corrects and restores p53 function. the company also develops product candidates for p53 r273h hotspot mutation and other p53 hotspot mutations. pmv pharmaceutical...s, inc. was formerly known as pj pharmaceuticals, inc. and changed to in july 2013. the company was founded in 2013 and is headquartered in cranbury, new jersey. Show More
Quarter analysis & expected interestLast update: February 09 2024 10:20:45.

After 39 days of this quarter the interest is at 25.0. Based on that we can calculate that during remaining 52 days it will total up to 58.0.
PMV Pharmaceuticals expected interest is significantly lower compared to same quarter last year (-62.3%) but similar to previous quarter.

YearQ1Q2Q3Q4
20190
48
inf% QoQ
145
202.1% QoQ
0
-100.0% QoQ
2020 39
inf% YoY inf% QoQ
57
18.8% YoY 46.2% QoQ
88
-39.3% YoY 54.4% QoQ
69
inf% YoY -21.6% QoQ
2021 242
520.5% YoY 250.7% QoQ
71
24.6% YoY -70.7% QoQ
138
56.8% YoY 94.4% QoQ
67
-2.9% YoY -51.4% QoQ
2022 70
-71.1% YoY 4.5% QoQ
104
46.5% YoY 48.6% QoQ
129
-6.5% YoY 24.0% QoQ
0
-100.0% YoY -100.0% QoQ
2023 154
120.0% YoY inf% QoQ
80
-23.1% YoY -48.1% QoQ
105
-18.6% YoY 31.2% QoQ
71
inf% YoY -32.4% QoQ
2024 25
-83.8% YoY -64.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and PMV Pharmaceuticals search interestLast update: February 09 2024 10:20:43.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 10:20:46.

The average 5 years interest of PMV Pharmaceuticals was 6.52 per week.
The last year interest of PMV Pharmaceuticals compared to the last 5 years has changed by 0.92%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 62.07%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for PMV Pharmaceuticals login to provide analysis

Correlation between past revenue and PMV Pharmaceuticals login search interest

There is not enough data for PMV Pharmaceuticals login to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for PMV Pharmaceuticals login to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 10:20:51.

After 39 days of this quarter the interest is at 32.0. Based on that we can calculate that during remaining 52 days it will total up to 75.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019100
39
-61.0% QoQ
153
292.3% QoQ
81
-47.1% QoQ
2020 31
-69.0% YoY -61.7% QoQ
112
187.2% YoY 261.3% QoQ
0
-100.0% YoY -100.0% QoQ
28
-65.4% YoY inf% QoQ
2021 64
106.5% YoY 128.6% QoQ
86
-23.2% YoY 34.4% QoQ
180
inf% YoY 109.3% QoQ
103
267.9% YoY -42.8% QoQ
2022 22
-65.6% YoY -78.6% QoQ
90
4.7% YoY 309.1% QoQ
39
-78.3% YoY -56.7% QoQ
125
21.4% YoY 220.5% QoQ
2023 98
345.5% YoY -21.6% QoQ
104
15.6% YoY 6.1% QoQ
31
-20.5% YoY -70.2% QoQ
104
-16.8% YoY 235.5% QoQ
2024 32
-67.3% YoY -69.2% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and PMV Pharmaceuticals stock search interestLast update: February 09 2024 10:20:50.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 10:20:52.

The average 5 years interest of PMV Pharmaceuticals stock was 6.21 per week.
The last year interest of PMV Pharmaceuticals stock compared to the last 5 years has changed by 14.33%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by -0.98%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for PMV Pharmaceuticals careers to provide analysis

Correlation between past revenue and PMV Pharmaceuticals careers search interest

There is not enough data for PMV Pharmaceuticals careers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for PMV Pharmaceuticals careers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for PMV Pharmaceuticals news to provide analysis

Correlation between past revenue and PMV Pharmaceuticals news search interest

There is not enough data for PMV Pharmaceuticals news to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for PMV Pharmaceuticals news to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for PMV Pharmaceuticals clinical trials to provide analysis

Correlation between past revenue and PMV Pharmaceuticals clinical trials search interest

There is not enough data for PMV Pharmaceuticals clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for PMV Pharmaceuticals clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for PMV Pharmaceuticals drug pipeline to provide analysis

Correlation between past revenue and PMV Pharmaceuticals drug pipeline search interest

There is not enough data for PMV Pharmaceuticals drug pipeline to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for PMV Pharmaceuticals drug pipeline to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for PMV Pharmaceuticals investor relations to provide analysis

Correlation between past revenue and PMV Pharmaceuticals investor relations search interest

There is not enough data for PMV Pharmaceuticals investor relations to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for PMV Pharmaceuticals investor relations to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 10:20:59.

After 39 days of this quarter the interest is at 411.0. Based on that we can calculate that during remaining 52 days it will total up to 959.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019608
889
46.2% QoQ
799
-10.1% QoQ
918
14.9% QoQ
2020 955
57.1% YoY 4.0% QoQ
754
-15.2% YoY -21.0% QoQ
863
8.0% YoY 14.5% QoQ
879
-4.2% YoY 1.9% QoQ
2021 766
-19.8% YoY -12.9% QoQ
806
6.9% YoY 5.2% QoQ
804
-6.8% YoY -0.2% QoQ
826
-6.0% YoY 2.7% QoQ
2022 882
15.1% YoY 6.8% QoQ
873
8.3% YoY -1.0% QoQ
797
-0.9% YoY -8.7% QoQ
879
6.4% YoY 10.3% QoQ
2023 1051
19.2% YoY 19.6% QoQ
943
8.0% YoY -10.3% QoQ
856
7.4% YoY -9.2% QoQ
1069
21.6% YoY 24.9% QoQ
2024 411
-60.9% YoY -61.6% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and cancer treatments search interestLast update: February 09 2024 10:20:59.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 10:21:00.

The average 5 years interest of cancer treatments was 67.54 per week.
The last year interest of cancer treatments compared to the last 5 years has changed by 9.31%.
The interest for cancer treatments is relatively stable in the last 5 years.
The last year interest is comparable to 5 years ago. It has changed only by 6.0%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for PMVP
Earnings date: 2024-02-28 After close
Company name: PMV Pharmaceuticals Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-13T17:14:46Z

Analyst Upgrades
Oppenheimer Maintains Outperform on PMV Pharmaceuticals, Lowers Price Target to $5

2026-05-12T12:00:00Z

GlobeNewswire
PMV Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Highlights

2026-04-22T12:00:00Z

GlobeNewswire
PMV Pharmaceuticals Announces Board Chair Transition

2026-03-06T13:00:00Z

GlobeNewswire
PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights

2026-02-26T13:00:00Z

GlobeNewswire
New England Journal of Medicine Publishes First-in-Human Rezatapopt Data Showing Selective Reactivation of Mutant p53 in Advanced Solid Tumors

2025-11-12T13:00:00Z

GlobeNewswire
PMV Pharmaceuticals Reports Third Quarter 2025 Financial Results and Corporate Highlights

2025-10-24T15:39:49Z

GlobeNewswire
PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation

2025-10-13T20:01:00Z

GlobeNewswire
PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase 2 Initial Analysis and Natural History Study Results at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

2025-09-23T20:34:40-04:00

SEC
SCHEDULE 13G Form - Statement of Beneficial Ownership by Certain Investors - PMV Pharmaceuticals, Inc. (0001699382) (Subject)

2025-09-12T17:09:08-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)

2025-09-10T18:50:45-04:00

SEC
144 Form - Report of proposed sale of securities - PMV Pharmaceuticals, Inc. (0001699382) (Subject)

2025-09-10T12:04:39-04:00

SEC
8-K Form - Current report, items 7.01, 8.01, and 9.01 - PMV Pharmaceuticals, Inc. (0001699382) (Filer)

2025-09-10T11:00:00Z

GlobeNewswire
PMV Pharmaceuticals Announces Promising Rezatapopt Monotherapy Interim Data From PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation

2025-08-07T12:42:03Z

GlobeNewswire
PMV Pharmaceuticals Reports Second Quarter 2025 Financial Results and Corporate Highlights

2025-08-07T08:00:55-04:00

SEC
10-Q Form - Quarterly report [Sections 13 or 15(d)] - PMV Pharmaceuticals, Inc. (0001699382) (Filer)